Literature DB >> 21403020

Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment.

Robert S Wilson1, Sue E Leurgans, Patricia A Boyle, David A Bennett.   

Abstract

OBJECTIVE: To characterize the course of cognitive decline during the prodromal phase of Alzheimer disease.
DESIGN: Longitudinal cohort study with up to 16 years of observation. PARTICIPANTS: Older persons from 2 studies underwent annual clinical evaluations that included cognitive function testing and clinical classification of mild cognitive impairment, dementia, and Alzheimer disease. At baseline, there were 2071 individuals without dementia and 1511 without cognitive impairment.
RESULTS: During follow-up, 462 persons developed Alzheimer disease (20 with dementia solely due to another condition were excluded). Five to six years before diagnosis, the rate of global cognitive decline accelerated more than 15-fold. The acceleration in cognitive decline occurred slightly earlier for semantic memory (76 months before diagnosis) and working memory (75 months) than other cognitive functions. Mild cognitive impairment was also preceded by years of cognitive decline that began earlier (80 months before diagnosis) and proceeded more rapidly (annual loss of 0.102 unit) in the amnestic than in the nonamnestic (62 months, 0.072 unit) subtype.
CONCLUSION: Dementia due to Alzheimer disease is preceded by about 5 to 6 years of accelerated decline in multiple cognitive functions. By contrast, little decline is evident in persons who do not develop Alzheimer disease.

Entities:  

Mesh:

Year:  2011        PMID: 21403020      PMCID: PMC3100533          DOI: 10.1001/archneurol.2011.31

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  36 in total

1.  MRI measures of entorhinal cortex vs hippocampus in preclinical AD.

Authors:  R J Killiany; B T Hyman; T Gomez-Isla; M B Moss; R Kikinis; F Jolesz; R Tanzi; K Jones; M S Albert
Journal:  Neurology       Date:  2002-04-23       Impact factor: 9.910

2.  The association of magnetic resonance imaging measures with cognitive function in a biracial population sample.

Authors:  Neelum T Aggarwal; Robert S Wilson; Julia L Bienias; Philip L De Jager; David A Bennett; Denis A Evans; Charles DeCarli
Journal:  Arch Neurol       Date:  2010-04

Review 3.  The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.

Authors:  Philip D Sloane; Sheryl Zimmerman; Chirayath Suchindran; Peter Reed; Lily Wang; Malaz Boustani; S Sudha
Journal:  Annu Rev Public Health       Date:  2001-10-25       Impact factor: 21.981

4.  Cognitive activity and the cognitive morbidity of Alzheimer disease.

Authors:  R S Wilson; L L Barnes; N T Aggarwal; P A Boyle; L E Hebert; C F Mendes de Leon; D A Evans
Journal:  Neurology       Date:  2010-09-01       Impact factor: 9.910

5.  A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease.

Authors:  C B Hall; R B Lipton; M Sliwinski; W F Stewart
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

6.  Cognitive decline in incident Alzheimer disease in a community population.

Authors:  R S Wilson; N T Aggarwal; L L Barnes; C F Mendes de Leon; L E Hebert; D A Evans
Journal:  Neurology       Date:  2010-03-23       Impact factor: 9.910

7.  Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes.

Authors:  Jing He; Sarah Farias; Oliver Martinez; Bruce Reed; Dan Mungas; Charles Decarli
Journal:  Arch Neurol       Date:  2009-11

8.  Natural history of mild cognitive impairment in older persons.

Authors:  D A Bennett; R S Wilson; J A Schneider; D A Evans; L A Beckett; N T Aggarwal; L L Barnes; J H Fox; J Bach
Journal:  Neurology       Date:  2002-07-23       Impact factor: 9.910

9.  Longitudinal study of the transition from healthy aging to Alzheimer disease.

Authors:  David K Johnson; Martha Storandt; John C Morris; James E Galvin
Journal:  Arch Neurol       Date:  2009-10

10.  Individual differences in rates of change in cognitive abilities of older persons.

Authors:  Robert S Wilson; Laurel A Beckett; Lisa L Barnes; Julie A Schneider; Julie Bach; Denis A Evans; David A Bennett
Journal:  Psychol Aging       Date:  2002-06
View more
  126 in total

Review 1.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

Review 2.  Anosognosia in Dementia.

Authors:  Robert S Wilson; Joel Sytsma; Lisa L Barnes; Patricia A Boyle
Journal:  Curr Neurol Neurosci Rep       Date:  2016-09       Impact factor: 5.081

3.  Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment.

Authors:  Sandhitsu R Das; Lauren Mancuso; Ingrid R Olson; Steven E Arnold; David A Wolk
Journal:  Cereb Cortex       Date:  2015-02-27       Impact factor: 5.357

4.  Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment.

Authors:  Elliott J Mufson; Michael Malek-Ahmadi; Sylvia E Perez; Kewei Chen
Journal:  Neurobiol Aging       Date:  2015-10-20       Impact factor: 4.673

5.  Conscientiousness, dementia related pathology, and trajectories of cognitive aging.

Authors:  Robert S Wilson; Patricia A Boyle; Lei Yu; Eisuke Segawa; Joel Sytsma; David A Bennett
Journal:  Psychol Aging       Date:  2015-02-09

6.  Longitudinal change in working memory as a function of APOE genotype in midlife and old age.

Authors:  Pamela M Greenwood; Thomas Espeseth; Ming-Kuan Lin; Ivar Reinvang; Raja Parasuraman
Journal:  Scand J Psychol       Date:  2014-06

Review 7.  The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Authors:  Napatkamon Ayutyanont; Jessica B S Langbaum; Suzanne B Hendrix; Kewei Chen; Adam S Fleisher; Michel Friesenhahn; Michael Ward; Camilo Aguirre; Natalia Acosta-Baena; Lucìa Madrigal; Claudia Muñoz; Victoria Tirado; Sonia Moreno; Pierre N Tariot; Francisco Lopera; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2014-06       Impact factor: 4.384

Review 8.  Postmenopausal hormone therapy is not associated with risk of all-cause dementia and Alzheimer's disease.

Authors:  Jacqueline O'Brien; John W Jackson; Francine Grodstein; Deborah Blacker; Jennifer Weuve
Journal:  Epidemiol Rev       Date:  2013-09-15       Impact factor: 6.222

9.  Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2013-09-17       Impact factor: 3.535

10.  Association of Childhood Lead Exposure With MRI Measurements of Structural Brain Integrity in Midlife.

Authors:  Aaron Reuben; Maxwell L Elliott; Wickliffe C Abraham; Jonathan Broadbent; Renate M Houts; David Ireland; Annchen R Knodt; Richie Poulton; Sandhya Ramrakha; Ahmad R Hariri; Avshalom Caspi; Terrie E Moffitt
Journal:  JAMA       Date:  2020-11-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.